IDXX
IDEXX Laboratories, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$535.38
+1.15%Forward multiples
Based on analyst estimates
- P/E forward
- 34.32x
- P/E 2026E
- 36.02x
- P/E 2027E
- 31.73x
- P/E 2028E
- 28.00x
- P/S forward
- 8.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.60x
- PEG TTM
- 3.92x
- Price / book
- 26.16x
- Price / sales
- 9.26x
- Price / cash flow
- 30.84x
Enterprise value
- Enterprise value
- $43.1B
- EV / sales
- 9.46x
- EV / EBITDA
- 26.63x
- EV / EBIT
- 29.53x
- Market cap
- $42.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026